ModalisX
Every Life Deserves Attention
Tokyo, Japan · Founded 2016
- Headquarters
- Tokyo
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- modalistx.com
About
Modalis Therapeutics (ModalisX) is a Tokyo-based clinical-stage biotech company pioneering epigenome editing as a treatment platform for genetic diseases. Founded in 2016 by Haru Morita and Osamu Nureki, the company developed CRISPR-GNDM®, a proprietary technology that selectively activates or suppresses specific genes without altering the DNA sequence, enabling therapies delivered via AAV vectors. Modalis is listed on the Tokyo Stock Exchange Mothers market (ticker 4883) and has active collaborative pipelines in muscular disorders, cardiomyopathy, CNS disorders, and FSHD.
Summary
ModalisX is a Biotech company based in Tokyo, Japan, founded in 2016.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/modalisx"><img src="https://indexed.vc/api/badge/company/modalisx" alt="ModalisX on Indexed.vc" width="260" height="76" /></a>